LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global laryngeal cancer therapeutics market is expected to post a
CAGR of over 7% during the period 2019-2023, according to the latest
market research report by Technavio.
The increasing use of tobacco products is the major factor for the
rising incidence of laryngeal cancer. The highest incidence of laryngeal
cancer is found among African-Americans, followed by Caucasians, in the
country. The strong mortality rate and the prevalence of the indication
are leading to an increase in the use of therapeutics such as
chemotherapy and targeted therapy for the treatment. Also, factors such
as the increasing incidence of HPV-caused cancers are driving the growth
of the market because of the metastatic nature of the virus. Hence, the
global laryngeal cancer therapeutics market is expected to benefit from
the increasing prevalence of the indication during the forecast period.
As per Technavio, the advent of novel therapies will have a positive
impact on the market and contribute to its growth significantly over the
forecast period. This global
laryngeal cancer therapeutics market 2019-2023 research
report also analyzes other important trends and market drivers that will
affect market growth over 2019-2023.
Global laryngeal cancer therapeutics market:
Advent of novel therapies
For a long time, the global laryngeal cancer therapeutics market had
chemotherapy as the only treatment option. However, the increasing
prevalence of the disease and the high mortality rate have resulted in
the need for more advanced therapies for the treatment of the disease.
As a result, the market has witnessed an increase in the research of
novel therapeutics such as targeted therapies, biologics, and
regenerative therapies for laryngeal cancer. For instance, gene therapy
is a type of novel therapy that is being studied intensively in the
early stages of the clinical trials. It involves editing/modifying a
gene in the laboratory and inserting it in the patient. The modified
gene helps in silencing the faulty gene or modifying the mutated gene in
the body, resulting in reversing the damage caused by the indication.
Advancements in the research of these novel therapies are expected to
add significant value to the growth of the global laryngeal cancer
therapeutics market in the coming years.
“Apart from the advent of novel therapies, the increasing number of
reimbursement programs, the growing number of strategic alliances, and
the increasing research grants are some major aspects that are expected
to boost the growth of the global market during the forecast period,” says
an analyst at Technavio.
Global laryngeal cancer therapeutics market:
Segmentation analysis
This market research report segments the global laryngeal cancer
therapeutics market by type (biologics and small molecules) and
geographical regions (North America, Europe, Asia, ROW).
The North American region led the market in 2018, followed by Europe,
Asia, and ROW respectively. During the forecast period, the North
American region is expected to continue dominating the global market as
well as register the highest incremental growth due to the increasing
preference for the treatment using therapeutics for various head and
neck cancer, including laryngeal cancer.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com